Voglibose with Metformin & Glimepiride

Voglibose with Metformin & Glimepiride is a combination medication used for the treatment of type 2 diabetes mellitus. It helps control blood sugar levels by different mechanisms, including reducing glucose absorption in the intestine (Voglibose), decreasing hepatic glucose production (Metformin), and enhancing insulin secretion (Glimepiride).

Indications

Management of type 2 diabetes mellitus in adults.

Dosage

-Dosage should be individualized based on patient's condition and response to treatment. -Typically, one tablet is taken orally with meals.

Contra-Indications

-Known hypersensitivity to any of the components. -Type 1 diabetes mellitus, diabetic ketoacidosis.

Special Precautions

-Renal impairment -Hepatic impairment -Elderly patients -Pregnancy and lactation

Side Effects

-Common: Hypoglycemia, gastrointestinal disturbances (e.g., nausea, diarrhea), weight gain. -Rare: Skin reactions, hepatic dysfunction.

Drug Interactions

Potential interactions with other antidiabetic medications, certain antibiotics, and drugs affecting liver enzymes.